NCT01910012View on ClinicalTrials.gov

PH 2 ADI-PEG 20 Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 6, 2015

Primary Completion Date

September 12, 2016

Study Completion Date

May 5, 2017

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

ADI-PEG 20

Trial Locations (6)

77030

MD Anderson, Houston

Unknown

Chang Gung Medical Foundation-Kaohsiung, Kaohsiung City

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

CMUH, Taichung

NCKUH, Tainan City

CGMH-LK, Taoyuan District

Sponsors

Lead Sponsor

Polaris Group
All Listed Sponsors
lead

Polaris Group

INDUSTRY